Huntington’s disease is a severe inherited neurodegenerative disorder lacking effective treatments. A UCL research team has pioneered AMT-130, a gene therapy showing promise in slowing disease progression. Early trials indicate safety and significant clinical benefits, marking a hopeful shift towards potentially transformative therapies for Huntington’s and similar conditions.